A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells - Wikidata - awgldk - TriplyDB

A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells

A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells

http://www.wikidata.org/entity/Q35153765

about

CAR models: next-generation CAR modifications for enhanced T-cell function Clinical manufacturing of CAR T cells: foundation of a promising therapy Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy Novel immunotherapies in lymphoid malignancies Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors Adoptive T-cell therapy for fungal infections in haematology patients Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute Leukemia Adoptive T-Cell Immunotherapy Lymphoma Immunotherapy: Current Status Synthetic biology approaches to engineer T cells Adoptive T-cell therapy for cancer: The era of engineered T cells CAR T Cell Therapy: A Game Changer in Cancer Treatment Adoptive T-cell therapy for Leukemia Adoptive cell therapy for sarcoma A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells Toxicity and management in CAR T-cell therapy T-cell receptor gene therapy--ready to go viral?Manufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapies Smart CARs engineered for cancer immunotherapy Designing chimeric antigen receptors to effectively and safely target tumors Engineering human T cells for resistance to methotrexate and mycophenolate mofetil as an in vivo cell selection strategy Strategies to genetically engineer T cells for cancer immunotherapy.In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults Emerging immunotherapeutics in adenocarcinomas: A focus on CAR-T cells Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo.Inclusion of Strep-tag II in design of antigen receptors for T-cell immunotherapy.Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy Driving CAR T-cells forward Universal artificial antigen presenting cells to selectively propagate T cells expressing chimeric antigen receptor independent of specificity.HSV-sr39TK positron emission tomography and suicide gene elimination of human hematopoietic stem cells and their progeny in humanized mice.Improving the safety of cell therapy products by suicide gene transfer Improving the safety of cell therapy with the TK-suicide gene Clinical application of genetically modified T cells in cancer therapy.CD19 CAR-targeted T cells induce long-term remission and B Cell Aplasia in an immunocompetent mouse model of B cell acute lymphoblastic leukemia.Safety of targeting ROR1 in primates with chimeric antigen receptor-modified T cells.Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity.Chimeric antigen receptors with mutated IgG4 Fc spacer avoid fc receptor binding and improve T cell persistence and antitumor efficacy IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors in vivo.A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16(ecto) directed chimeric antigen receptors for recurrent ovarian cancer.

P2860

Q26745600-B9861551-AD8F-4C05-BF77-B5791C0B188C Q26747037-9B23FF7A-1CD9-47A8-86AD-2E75E021D383 Q26773309-0EFDF13A-573E-4972-81FE-C39ED561A8D3 Q26777394-1B8B8371-4707-44E5-A79D-0E5518C82E0B Q26778759-BC23770E-1C7E-4E63-BEB3-123F92C1415A Q26781064-B9DC355B-1647-4191-8CC1-7E2438264BB2 Q26781328-78A45E9D-2208-4027-A864-BAED133C4D93 Q26782845-73C9DAD5-000C-474C-8149-67D7D82A797A Q26782902-FD407443-8C61-4828-B67C-072254BA3471 Q26798366-170BFD9A-7293-475A-9E22-D875C07C3BFA Q26800611-FB20BB2D-4582-410D-B25C-44331E777863 Q26822769-E4F33D93-73B1-48E9-80AC-81663B628CB3 Q27006934-A8A934A8-7AB0-4E79-A33E-E0FA04A10C34 Q27009541-F83760EB-34C3-4360-BF68-A41C54F32409 Q27345360-A6931340-AB07-4AC9-8DDB-FDAB13156D6E Q28075314-032D2B12-CADF-424D-B6BA-B6061F1FD3A0 Q28081611-99C60B1C-C8DF-491D-8AAA-BDEDD1E28C8D Q28085769-451D5832-7197-4544-8972-17393BCBBD86 Q28087236-3B93A63E-865F-4938-B26A-A2089A885EF0 Q28088526-39CAC1D7-DA4F-4D3B-8D59-7BD07F8ED451 Q28533690-51761744-B6EC-4381-934F-5455E48D40F1 Q33655849-6A4AB41D-2CE4-4363-ADB3-F48944FDD6CB Q33716478-5974B57E-CAE5-4B5C-AB2C-8D71A428ACC0 Q33827997-8B3237F4-EAAC-45E1-BBC5-5E1FC582F9F9 Q33833475-F774C363-A0C9-408E-A66E-93CC86BEE933 Q34044910-ECEF1FC5-5A0B-4C9D-BD9B-AFD34FFAB996 Q34046252-78B4FFCE-62E9-4E1F-9F6E-5905E29F5F04 Q34046263-5C6D7BAE-2581-47F7-A520-78E631FE8A4A Q34046505-1E49083A-EDC0-4E45-8F09-3412B37DDAE6 Q34069803-CCBC23F1-A87E-48CF-B8B9-0B8218DB8F08 Q34204696-05DAF028-A7CC-43F4-843E-545C7DF67615 Q34453846-ADCBF145-2D52-4670-B56F-4E648349C246 Q34477411-A2B4D690-27B6-4948-AA38-41FBCA371AFA Q34511646-9563F2BB-C76B-48F9-AC61-79CE88A3EF66 Q34667972-E99CDC9F-5F80-48C3-9CAC-D53EFAF18B94 Q35071430-44858856-6DF5-4A1F-8DB9-BF872C5F73E9 Q35216278-9AF4E1CA-B8E9-4874-B135-5BE715A90B85 Q35399080-6221CE05-2B06-4CC4-9D8D-B6D66AB97DDE Q35506724-5A234CC5-B41C-49B6-994E-19C13FFB0F30 Q35627284-99C97B26-6826-442A-86B3-739459015EC8

P2860

A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells

http://www.wikidata.org/entity/Q35153765

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

A transgene-encoded cell surfa ...... d ablation of engineered cells

@ast

A transgene-encoded cell surfa ...... d ablation of engineered cells

@en

type

label

A transgene-encoded cell surfa ...... d ablation of engineered cells

@ast

A transgene-encoded cell surfa ...... d ablation of engineered cells

@en

prefLabel

A transgene-encoded cell surfa ...... d ablation of engineered cells

@ast

A transgene-encoded cell surfa ...... d ablation of engineered cells

@en

P1433

Q35153765-C00AF16A-3212-4EB0-AEE2-1EB786DBF636

P1476

Q35153765-6427F212-4B71-45A6-9943-4D6855EFABFE

P2093

Q35153765-1157897F-7859-4699-BDC1-5796831CF55A

Q35153765-4422ED61-C5C8-4973-976C-5372AF9B3BAC

Q35153765-49D5D612-1622-4090-A087-6E9AB98806A1

Q35153765-9803C764-C69E-44C8-81C2-7BE2367B659E

Q35153765-B8C307A1-5429-441A-86CE-B3022CBEC45D

Q35153765-C41C7C4C-F4F1-4924-9AAC-6F4F6325B2CC

Q35153765-ECEAA502-C645-4AF2-A45E-43CA25F0C00E

Q35153765-F1A2649B-7B27-4DAA-8934-84751FA1643B

Q35153765-FAC5A93F-1FD4-4152-9573-30A4F0A5AB70

P2860

Q35153765-094FBD51-CC2C-43A0-B2D1-128DB625431A

Q35153765-0C41CF0A-C664-409D-BECF-CDCD788062C2

Q35153765-0ED41685-7881-4F72-88FD-9BD743DB1169

Q35153765-10C1C116-7047-4186-98D6-EBC86351B109

Q35153765-28CAFDA8-250B-4C3E-ADAE-2315DDF6D852

Q35153765-2D4BEBA5-77AC-4F7B-B6D1-360672D2F44B

Q35153765-2EB5C681-C490-4209-9103-6F56C1A1857C

Q35153765-2FF3DDA6-6C71-4F36-B808-59890836BC67

Q35153765-35C7D101-A19F-4A1B-944F-F78FC47E8C14

Q35153765-37E56754-B460-4DE7-A3F3-1AACDADA9566

P304

Q35153765-9719136F-67C4-4D6C-B5F1-3B7627C6FFA3

P31

Q35153765-966B3E6C-0939-47DE-87E0-CBC8D13347D7

P356

Q35153765-6F892D90-90D6-456B-BC9B-18179361C7C6

P407

Q35153765-497B1C1E-4426-47C3-AB06-EE554063EAE9

P433

Q35153765-ACE2CB17-34D0-46DD-B144-CF608ACEBFD3

P478

Q35153765-B440CC71-A30C-4BF6-AAAC-7F048A5B3BDA

P577

Q35153765-D98AAAE6-36FC-4516-8BFB-2AA3832F445C

P5875

Q35153765-9F7DE0E2-24AA-46E4-8732-BA3EA4BCEA4E

P698

Q35153765-941A5170-8F38-4A6C-8D03-DDABBE813559

P932

Q35153765-DC21455B-0319-4B26-B818-3AF4CC862971

P356

BLOOD-2011-02-337360

P1433

P1476

A transgene-encoded cell surfa ...... d ablation of engineered cells

@en

P2093

ChingLam W Wong

http://www.w3.org/2001/XMLSchema#string

David Colcher

http://www.w3.org/2001/XMLSchema#string

Julie R Ostberg

http://www.w3.org/2001/XMLSchema#string

Mark Sherman

http://www.w3.org/2001/XMLSchema#string

Michael C Jensen

http://www.w3.org/2001/XMLSchema#string

Stanley R Riddell

http://www.w3.org/2001/XMLSchema#string

Stephen J Forman

http://www.w3.org/2001/XMLSchema#string

Wen-Chung Chang

http://www.w3.org/2001/XMLSchema#string

Xiuli Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface

Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice

Dose translation from animal to human studies revisited

Peptide mimotopes recognized by antibodies cetuximab and matuzumab induce a functionally equivalent anti-EGFR immune response.

Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice

Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation.

Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans.

T-cell genetic modification for re-directed tumor recognition.

Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition

Structure-based view of epidermal growth factor receptor regulation.

P304

1255-1263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2011-02-337360

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51201483

http://www.w3.org/2001/XMLSchema#string

P698

21653320

http://www.w3.org/2001/XMLSchema#string

P932

3152493

http://www.w3.org/2001/XMLSchema#string